David Garfield is global co-CEO and a member of the Board of Directors of AlixPartners. He has over 30 years of extensive industry experience as an executive and consultant, working closely with board members and senior executives to develop winning strategies and drive growth in shareholder value. He serves on the Board of Directors of Lurie Children’s Hospital of Chicago. He has also served as an Advisory Board Member of Oxford University’s Enacting Purpose Initiative (“EPI”), a global group of leading members of large corporate Boards of Directors aimed at defining the role of “purpose” in corporate governance.
Additionally, Garfield is an Advisory Board Member of The Financial Times’ Outstanding Directors Exchange (“ODX”), where he advises The Financial Times on nominations and selections for Outstanding Directors of the Year.
He is a frequent contributor to media outlets, including The Financial Times, The Economist, The Wall Street Journal, Bloomberg TV, National Public Radio, Harvard Business Review, Fortune Magazine and The New York Times, among others. He earned a BA in Psychology from Williams College and holds an MBA from Northwestern University's J.L. Kellogg Graduate School of Management, where he has also served as a guest lecturer to the Executive MBA programme.
